News
CooperCompanies Stock Drops After It Reports Weaker-Than-Estimated Quarterly Sales
Key Takeaways
CooperCompanies ( COO ) shares fell 8% Friday, a day after the maker of medical equipment posted worse-than-expected quarterly sales.
The company reported first-quarter fiscal 2025 adjusted earnings per share (EPS ) of 92 cents, in line with estimates from analysts who follow CooperCompanies and were polled by Visible Alpha. Its revenue rose 5% year-over-year to $964.7 million, missing estimates .
The share-price decline came even as the California-based company raised its full-year earnings outlook, forecasting fiscal 2025 adjusted EPS in the range of $3.94 to $4.02, up from a $3.92 to $4.02 range. The range was within consensus estimates of $3.99, though the midpoint was a bit below it.
CEO Al White said the company’s results met its revenue expectations and surpassed operational targets. The company, which has two business units—CooperVision and CooperSurgical—also projected fiscal 2025 total revenue between $4.08 billion and $4.16 billion, up between 6% and 8% year-over-year. Analysts polled by Visible Alpha were looking for $4.1 billion.
CooperCompanies shares reached their lowest price since November 2023 intraday Friday and have lost nearly 18% of their value in the past 12 months.
Read the original article on Investopedia